Migraine Prevention Drug Receives FDA Approval: Aimovig By Amgen Is The First Of Its Kind Aimovig, designed for long-term migraine prevention, will now go on sale after receiving approval from the U.S. Food and Drug Administration. The drug is the first of its kind, and it could soon mean the end of chronic migraines. by Aaron Mamiit
Health Vitamin Deficiency Linked To Recurrent And Chronic Migraines: Can Supplements Help? by Rhodi Lee
Healthy Living/Wellness Pre-Existing Asthma Early Indicator Of Chronic Migraine Attacks: Study by Dianne Depra